CSL Vifor
| Company type | Public |
|---|---|
| SIX: VIFN | |
| ISIN | CH0364749348 |
| Industry | Pharmaceutical |
| Founded | 1927 |
| Headquarters | |
Areas served | Worldwide |
Key people | Hervé Gisserot (General Manager) |
| Revenue | CHF 1.75 billion (2021) |
| Parent | CSL Limited |
| Website | www |
CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Sanifit Therapeutics.